The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: A retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi

Annals of Oncology

Volumn 24, Issue 8, 2013, Pages 2108-2112

  Luminari, S ^a   Biasoli, I ^b   Arcaini, L ^c,d   Versari, A ^e   Rusconi, C ^f   Merli, F ^e   Spina, M ^g   Ferreri, A J M ^h   Zinzani, P L ⁱ   Gallamini, A ^j   Mastronardi, S ^a   Boccomini, C ^k   Gaidano, G ^l   D'Arco, A M ^m   Di Raimondo, F ⁿ   Carella, A M ^o   Santoro, A ^p   Musto, P ^q   Federico, M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ L and A Seràgnoli Hematology and Oncological Sciences Institute   (Italy)

^j S CROCE E CARLE HOSPITAL   (Italy)

^k CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^l UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^m Onco Ematologia Nocera Inf Pagani   (Italy)

ⁿ UNIVERSITY OF CATANIA   (Italy)

^o UNIVERSITY OF GENOA   (Italy)

^p HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^q REFERRAL CANCER CENTER OF BASILICATA   (Italy)

more..

Author keywords

CT scan; FDG PET; Follicular lymphoma; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE LESION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLICULAR LYMPHOMA; GASTROINTESTINAL TUMOR; HUMAN; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN TUMOR; SOFT TISSUE TUMOR; SPLEEN TUMOR;

CT SCAN; FDG-PET; FOLLICULAR LYMPHOMA; STAGING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; ITALY; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 84881229624     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt137     Document Type: Article

References (23)

1. Freedman A. Follicular lymphoma: 2011 update on diagnosis and management. Am J Hematol 2011; 86: 768-775.
2. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-578.
3. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
4. Meignan M, Gallamini A, Haioun C, et al. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010. Leuk Lymphoma 2012; 51: 2171-2180.
5. Tsukamoto N, Kojima M, Hasegawa M, et al. The usefulness of (18)Ffluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer 2007; 110: 652-659.
6. Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101: 3875-3876.
7. Wohrer S, Jaeger U, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 2006; 17: 780-784.
8. Le Dortz L, De Guibert S, Bayat S, et al. Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 2010; 37: 2307-2314.
9. Wirth A. PET for follicular lymphoma: a work in progress! Leuk Lymphoma 2007; 48: 1463-1464.
10. Janikova A, Bolcak K, Pavlik T, et al. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?. Clin Lymphoma Myeloma 2008; 8: 287-293.
11. Karam M, Novak L, Cyriac J, et al. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107: 175-183.
12. Blum RH, Seymour JF, Wirth A, et al. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clin Lymphoma 2003; 4: 43-49.
13. Trotman J, Fournier M, Lamy T, et al. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol 2011; 29: 3194-3200.
14. Dupuis J, Berriolo-Riedinger A, Julian A, et al. Impact of [18F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS. J Clin Oncol 2012; 30: 4317-4322.
15. Federico M, Luminari S, Dondi A, et al. R-Cvp Vs R-Chop Vs R-Fm for the initial treatment of patients with advanced stage follicular lymphoma: preliminary results of Foll05 Iil trial. Ann Oncol 2011; 22: 128-128.
16. Barosi G, Carella A, Lazzarino M, et al. Management of nodal indolent (nonmarginal- zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. Haematologica 2005; 90: 1236-1257.
17. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
18. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
20. Bishu S, Quigley JM, Bishu SR, et al. Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma. Leuk Lymphoma 2007; 48: 1548-1555.
21. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. J Clin Oncol 2004; 22: 1454-1459.
22. Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 2009; 27: 4555-4562.
23. Safar V, Dupuis J, Itti E, et al. Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracyclinebased chemotherapy plus rituximab. J Clin Oncol 2012; 30: 184-190.